UNSPSC 51385702: Nimesulide

This classification denotes a cyclooxygenase inhibitor with the molecular formula C13H12N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V4TKW1454M, chemically known as methanesulfonanilide, 4-nitro-2-phenoxy- but generally known as nimesulide, which bears US NIH Compound Identifier 4495. European Medicines Agency schedules Nimesulide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09294MIG.

UNSPSC 51385702 Nimesulide is a Commodity code for a specific nonsteroidal anti-inflammatory drug, though recent state and local procurement activity under this code does not reflect purchases of the drug itself. Instead, the single recent solicitation tagged to the code shows Seminole County, Florida procuring naloxone and drug deactivation systems—products unrelated to nimesulide's therapeutic scope. This mismatch suggests the code may be miscoded in the county's procurement system or the tagging reflects a data entry error rather than intentional drug procurement activity under this commodity line.

Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement included standard state and local requirements—electronic submission through the county's e-Procurement Portal, drug-free workplace certification, E-Verify compliance, and insurance coverage (workers' compensation, general liability, professional liability). The contract carried a two-year initial term with a one-year renewal option and a three-month probationary period. The solicitation noted potential FEMA funding and associated federal compliance obligations. No explicit set-aside or disadvantaged-enterprise designation appeared in the notice. The lack of additional recent opportunities under this code and the fundamental mismatch between nimesulide and the naloxone procurement suggest this code sees minimal relevant state and local activity, and opportunities tagged to it may reflect miscoding rather than genuine procurement intent for this pharmaceutical commodity.